Clinuvel Pharmaceuticals
CUV.AX
#7536
Rank
S$0.51 B
Marketcap
S$10.27
Share price
1.69%
Change (1 day)
10.30%
Change (1 year)

Earnings for Clinuvel Pharmaceuticals (CUV.AX)

Earnings in 2025: S$42.84 Million

According to Clinuvel Pharmaceuticals's latest financial reports the company's current earnings are S$62.5 Million. In 2025 the company made an earning of S$42.84 Million, an increase over its 2024 earnings that were of S$42.73 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clinuvel Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025S$42.84 M0.26%
2024S$42.73 M11.35%
2023S$38.37 M28.31%
2022S$29.9 M22.8%
2021S$24.35 M112.63%
2020S$11.45 M-28.73%
2019S$16.07 M32.79%
2018S$12.1 M75.41%
2017S$6.9 M-332.52%
2016-S$2.97 Million-70.68%
2015-S$10.13 Million53.78%
2014-S$6.59 Million-16.1%
2013-S$7.85 Million-37.92%
2012-S$12.64 Million-18.19%
2011-S$15.45 Million25.31%
2010-S$12.33 Million-21.53%
2009-S$15.72 Million-11.27%
2008-S$17.71 Million80.4%
2007-S$9.82 Million-2.46%
2006-S$10.07 Million-5.35%
2005-S$10.64 Million60.55%
2004-S$6.63 Million97.37%
2003-S$3.36 Million50.62%
2002-S$2.23 Million121.22%
2001-S$1.01 Million254.48%
2000-S$0.29 Million